Evidence map›Paper›PMID 40750279›Full record

ArticleBMJ open2025

Protocol for developing a core outcome set for medicines safety at transitions of care: a systematic review, qualitative study and Delphi consensus.

Ryan Jayesinghe, Ibidun Fakoya, Fiona Boland, Mariam Molokhia, Lise M Bjerre, C Alice Oborne, Carmel Hughes, Tamasine C Grimes, Patrick Redmond

Abstract read
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ryan JayesingheDepartment of General Practice, RCSI University of Medicine and Health Sciences, Dublin, Ireland ryanjaye1@icloud.com.ORCID http://orcid.org/0000-0002-7518-4970
Ibidun FakoyaDepartment of Women and Children's Health, King's College London, London, UK.ORCID http://orcid.org/0000-0003-3490-7607
Fiona BolandRCSI University of Medicine and Health Sciences, Dublin, Ireland.ORCID http://orcid.org/0000-0003-3228-0046
Mariam MolokhiaClinical Reader in Epidemiology and Primary Care, School of Life Course and Population Sciences, King's College London, London, UK.ORCID http://orcid.org/0000-0002-1989-7327
Lise M BjerreDepartment of Family Medicine and School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.ORCID http://orcid.org/0000-0003-3634-3585
C Alice OborneGuy's and St Thomas' NHS Foundation Trust, London, UK.ORCID http://orcid.org/0000-0001-8391-2061
Carmel HughesPrimary Care Research Group, School of Pharmacy, Queen's University Belfast, Belfast, UK.ORCID http://orcid.org/0000-0002-4656-6021
Tamasine C GrimesSchool of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland.ORCID http://orcid.org/0000-0002-7154-3243
Patrick RedmondDepartment of General Practice, Royal College of Surgeons in Ireland, Dublin, Ireland.ORCID http://orcid.org/0000-0002-3929-2018

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMedication-related problems at transitions of care are common and can lead to patient harm. Comparing results of studies that look at medication reconciliation and medication safety at transitions of care can be difficult as the outcomes reported in these studies are heterogeneous. Moreover, the outcomes measured often lack the patient's perspective. A core outcome set (COS) is a list of outcomes which should be measured and reported in studies in order to avoid heterogeneity between trials, measure outcomes relevant to stakeholders and ensure all trials report usable information. This study aims to develop a COS for medicines safety at transitions of care, through updating an existing systematic review and evaluating the perspectives of patients, carers and healthcare professionals.

methodsThis study is registered with the Core Outcome Measures in Effective Trials (COMET) initiative and the project will be conducted following the COS-STAR (Core Outcome Set-Standards for Reporting) guidelines for the design and reporting of COSs. A four-step process will be followed: (1) updating an existing systematic literature review; (2) semistructured interviews with patients and their caregivers; (3) Delphi survey preparation involving a project steering group to compile a list of potential outcomes; (4) a three-round Delphi consensus exercise involving patients, clinicians and policymakers to refine the final core list of outcomes. ANALYSIS: This will be the first COS for medicines safety at transitions of care and will address an unmet need in providing an essential measurement approach that incorporates patients', carers' and healthcare professionals' views. The findings apply to both quality improvement and research, ensuring the relevance and translation of future research findings. ETHICS AND DISSEMINATION: Ethical approval for the qualitative surveys and Delphi technique has been granted by the Irish College of General Practitioners Research Ethics Committee (Record ID: 2182). The findings of this project will be disseminated through peer-reviewed publications, conference presentations and registration with the COMET Initiative. Members of the Delphi panel will receive summaries of the outputs, and findings will also be shared with the patient and public involvement groups involved in the study through lay summaries. Engagement with professional societies, healthcare organisations and patient groups will ensure that the COS is widely accessible and adopted into future practice.

Indexed as

Medication ReconciliationOutcome Assessment, Health CareConsensusConsensus Statements as TopicDelphi TechniqueHumansPatient SafetyQualitative ResearchResearch DesignSystematic Reviews as TopicDelphi TechniqueMedication ReconciliationQUALITATIVE RESEARCHSystematic Review

Identifiers

PMID40750279
PMCPMC12314993

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.